Focus On Wholeness
March 2021
Guest Interview: Paolo Aquilini
March 31, 2021 • Pastor Dave Koop
Paolo Aquilini is a managing partner of the family owned and operated Aquilini Investment Group. AIG is one of Vancouver’s most diversified companies, best known for owning the Vancouver Canucks NHL hockey team and Rogers Arena. Paolo is actively involved in a variety of charities and President of Canucks for Kids Fund, the charitable arm of the Vancouver Canucks. Other passions that Paolo focuses his time on are mental health awareness.
Guest Interview: Dr. Casey Treat
March 29, 2021 • Pastor Dave Koop
Casey Treat shares the straightforward message that through God’s Word, you can change. Through the renewing of the mind to the Word and the power of the Holy Spirit, we can all live a victorious and prosperous Christian life here on this earth. Casey Treat is a pastor, author and motivational speaker, as well as the founder and president of Vision College (formally Dominion College). He also hosts a weekly television program called “Successful Living”.
Guest Interview: Dr. Gregory Jantz
March 25, 2021 • Pastor Dave Koop
Dr. Jantz is a best-selling author of 39 books, including his latest groundbreaking Healing Depression For Life. He is a go-to media source expert for a range of behavioral-based afflictions, as well as drug and alcohol addictions. Dr. Jantz has appeared on CNN, FOX, ABC, CBS, is a regular contributor to The Huffington Post and Psychology Today blogs.
Guest Interview: Dr. Caroline Leaf
March 21, 2021 • Pastor Dave Koop
Dr. Caroline Leaf is a communication pathologist and cognitive neuroscientist with a Masters and PhD in Communication Pathology and a BSc Logopaedics, specializing in cognitive and metacognitive neuropsychology. Since the early 1980s she has researched the mind-brain connection, the nature of mental health, and the formation of memory.
Guest Interview: Dr. Santa Ono
March 14, 2021 • Pastor Dave Koop
A molecular immunologist educated at the University of Chicago and McGill, Dr. Ono has taught at Johns Hopkins, Harvard University and University College London. He has advised national and regional governments on higher education and mental health. He has also advised companies such as GSK, Johnson & Johnson, Merck and Novartis on R&D.